Structures of known NMDAR
channel blockers and negative allosteric
modulators; memantine (1), dextromethorphan (2), amantadine (3), ketamine (4) ifenprodil
(5),8,9 DQP-110511 (6), QNZ-4610 (7), NAB-1415 (8), TCN-20113 (9, a GluN2A-selective negative
allosteric modulator that acts by reducing glycine affinity), and
EVT-101 (10).16